Chronic Embolic Pulmonary Hypertension Caused by Pulmonary Embolism and Vascular Endothelial Growth Factor Inhibition

American Journal of Pathology

Volumn 187, Issue 4, 2017, Pages 700-712

  Neto Neves, Evandro M ^a   Brown, Mary B ^b   Zaretskaia, Maria V ^a   Rezania, Samin ^a   Goodwill, Adam G ^a   McCarthy, Brian P ^a   Persohn, Scott A ^a   Territo, Paul R ^a   Kline, Jeffrey A ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; MICROSPHERE; OXYGEN; PLASTIC; POLYSTYRENE; SEMAXANIB; SODIUM CHLORIDE; VASCULOTROPIN; VASCULOTROPIN INHIBITOR; INDOLE DERIVATIVE; PADGEM PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYSTYRENE DERIVATIVE; PYRROLE DERIVATIVE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; VASCULOTROPIN A;

AEROBIC EXERCISE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ECHOCARDIOGRAPHY; HEART PERFUSION; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE HYPERTROPHY; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HYPOKINESIA; HYPOXIA-INDUCED PULMONARY HYPERTENSION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; ISOLATED HEART; LUNG; LUNG ANGIOGRAPHY; LUNG EMBOLISM; MALE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OXYGEN CONSUMPTION; PHENOTYPE; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION; PULMONARY HYPERTENSION; RAT; SHAM PROCEDURE; SINGLE DRUG DOSE; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; CARDIOMEGALY; CHRONIC DISEASE; COMPLICATION; DIAGNOSTIC IMAGING; DRUG EFFECTS; HEART FUNCTION TEST; HEART VENTRICLE FUNCTION; HEMODYNAMICS; HYPERPLASIA; HYPERTENSION, PULMONARY; HYPOXIA; METABOLISM; PARTIAL PRESSURE; PATHOLOGY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; CARDIOMEGALY; CELL PROLIFERATION; CHRONIC DISEASE; HEART FUNCTION TESTS; HEMODYNAMICS; HYPERPLASIA; HYPERTENSION, PULMONARY; HYPOXIA; INDOLES; KI-67 ANTIGEN; LUNG; MALE; MICROSPHERES; OXYGEN CONSUMPTION; P-SELECTIN; PARTIAL PRESSURE; PHYSICAL CONDITIONING, ANIMAL; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYSTYRENES; PULMONARY EMBOLISM; PYRROLES; RATS, SPRAGUE-DAWLEY; TISSUE INHIBITOR OF METALLOPROTEINASE-1; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VENTRICULAR DYSFUNCTION;

EID: 85016087732     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2016.12.004     Document Type: Article

References (49)

1. 1 Simonneau, G., Galie, N., Rubin, L.J., Langleben, D., Seeger, W., Domenighetti, G., Gibbs, S., Lebrec, D., Speich, R., Beghetti, M., Rich, S., Fishman, A., Clinical classification of pulmonary hypertension. J Am Coll Cardiol 43 (2004), 5S–12S.
2. 2 Simonneau, G., Gatzoulis, M.A., Adatia, I., Celermajer, D., Denton, C., Ghofrani, A., Gomez Sanchez, M.A., Krishna Kumar, R., Landzberg, M., Machado, R.F., Olschewski, H., Robbins, I.M., Souza, R., Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 62 (2013), D34–D41.
3. 3 Lang, I., Chronic thromboembolic pulmonary hypertension: a distinct disease entity. Eur Respir Rev 24 (2015), 246–252.
4. 4 Lang, I.M., Madani, M., Update on chronic thromboembolic pulmonary hypertension. Circulation 130 (2014), 508–518.
5. 5 Pengo, V., Lensing, A.W., Prins, M.H., Marchiori, A., Davidson, B.L., Tiozzo, F., Albanese, P., Biasiolo, A., Pegoraro, C., Iliceto, S., Prandoni, P., Thromboembolic Pulmonary Hypertension Study Group. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 350 (2004), 2257–2264.
6. 6 Pepke-Zaba, J., Delcroix, M., Lang, I., Mayer, E., Jansa, P., Ambroz, D., Treacy, C., D'Armini, A.M., Morsolini, M., Snijder, R., Bresser, P., Torbicki, A., Kristensen, B., Lewczuk, J., Simkova, I., Barbera, J.A., de Perrot, M., Hoeper, M.M., Gaine, S., Speich, R., Gomez-Sanchez, M.A., Kovacs, G., Hamid, A.M., Jais, X., Simonneau, G., Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation 124 (2011), 1973–1981.
7. 7 Yaoita, N., Shirakawa, R., Fukumoto, Y., Sugimura, K., Miyata, S., Miura, Y., Nochioka, K., Miura, M., Tatebe, S., Aoki, T., Yamamoto, S., Satoh, K., Kimura, T., Shimokawa, H., Horiuchi, H., Platelets are highly activated in patients of chronic thromboembolic pulmonary hypertension. Arterioscler Thromb Vasc Biol 34 (2014), 2486–2494.
8. 8 Lang, I.M., Pesavento, R., Bonderman, D., Yuan, J.X., Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding. Eur Respir J 41 (2013), 462–468.
9. 9 Tiede, S.L., Gall, H., Dorr, O., Troidl, C., Liebetrau, C., Voss, S., Voswinckel, R., Schermuly, R.T., Seeger, W., Grimminger, F., Zeiher, A.M., Dimmeler, S., Mollmann, H., Hamm, C.W., Ghofrani, H.A., Nef, H.M., New potential diagnostic biomarkers for pulmonary hypertension. Eur Respir J 46 (2015), 1390–1396.
10. 10 Quarck, R., Wynants, M., Verbeken, E., Meyns, B., Delcroix, M., Contribution of inflammation and impaired angiogenesis to the pathobiology of chronic thromboembolic pulmonary hypertension. Eur Respir J 46 (2015), 431–443.
11. 11 Zabini, D., Heinemann, A., Foris, V., Nagaraj, C., Nierlich, P., Balint, Z., Kwapiszewska, G., Lang, I.M., Klepetko, W., Olschewski, H., Olschewski, A., Comprehensive analysis of inflammatory markers in chronic thromboembolic pulmonary hypertension patients. Eur Respir J 44 (2014), 951–962.
12. 12 Mayer, E., Surgical and post-operative treatment of chronic thromboembolic pulmonary hypertension. Eur Respir Rev 19 (2010), 64–67.
13. 13 Ghofrani, H.A., D'Armini, A.M., Grimminger, F., Hoeper, M.M., Jansa, P., Kim, N.H., Mayer, E., Simonneau, G., Wilkins, M.R., Fritsch, A., Neuser, D., Weimann, G., Wang, C., CHEST-1 Study Group. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med 369 (2013), 319–329.
14. 14 Mercier, O., Fadel, E., Chronic thromboembolic pulmonary hypertension: animal models. Eur Respir J 41 (2013), 1200–1206.
15. 15 Committee for the Update of the Guide for the Care and Use of Laboratory Animals; National Research Council. Guide for the Care and Use of Laboratory Animals. ed 8, 2011, National Academies Press, Washington, DC.
16. 16 Watts, J.A., Gellar, M.A., Obraztsova, M., Kline, J.A., Zagorski, J., Role of inflammation in right ventricular damage and repair following experimental pulmonary embolism in rats. Int J Exp Pathol 89 (2008), 389–399.
17. 17 Watts, J.A., Zagorski, J., Gellar, M.A., Stevinson, B.G., Kline, J.A., Cardiac inflammation contributes to right ventricular dysfunction following experimental pulmonary embolism in rats. J Mol Cell Cardiol 41 (2006), 296–307.
18. 18 Spiekermann, K., Faber, F., Voswinckel, R., Hiddemann, W., The protein tyrosine kinase inhibitor SU5614 inhibits VEGF-induced endothelial cell sprouting and induces growth arrest and apoptosis by inhibition of c-kit in AML cells. Exp Hematol 30 (2002), 767–773.
19. 19 Hislop, A., Reid, L., Normal structure and dimensions of the pulmonary arteries in the rat. J Anat 125 (1978), 71–83.
20. 20 Molthen, R.C., Karau, K.L., Dawson, C.A., Quantitative models of the rat pulmonary arterial tree morphometry applied to hypoxia-induced arterial remodeling. J Appl Physiol (1985) 97 (2004), 2372–2384 discussion 54.
21. 21 Runyon, M.S., Gellar, M.A., Sanapareddy, N., Kline, J.A., Watts, J.A., Development and comparison of a minimally-invasive model of autologous clot pulmonary embolism in Sprague-Dawley and Copenhagen rats. Thromb J, 8, 2010, 3.
22. 22 Frump, A.L., Goss, K.N., Vayl, A., Albrecht, M., Fisher, A., Tursunova, R., Fierst, J., Whitson, J., Cucci, A.R., Brown, M.B., Lahm, T., Estradiol improves right ventricular function in rats with severe angioproliferative pulmonary hypertension: effects of endogenous and exogenous sex hormones. Am J Physiol Lung Cell Mol Physiol 308 (2015), L873–L890.
23. 23 Bogaard, H.J., Natarajan, R., Henderson, S.C., Long, C.S., Kraskauskas, D., Smithson, L., Ockaili, R., McCord, J.M., Voelkel, N.F., Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure. Circulation 120 (2009), 1951–1960.
24. 24 Brown, M.B., Chingombe, T.J., Zinn, A.B., Reddy, J.G., Novack, R.A., Cooney, S.A., Fisher, A.J., Presson, R.G., Lahm, T., Petrache, I., Novel assessment of haemodynamic kinetics with acute exercise in a rat model of pulmonary arterial hypertension. Exp Physiol 100 (2015), 742–754.
25. 25 Bedford, T.G., Tipton, C.M., Wilson, N.C., Oppliger, R.A., Gisolfi, C.V., Maximum oxygen consumption of rats and its changes with various experimental procedures. J Appl Physiol Respir Environ Exerc Physiol 47 (1979), 1278–1283.
26. 26 Liu, J., Rigel, D.F., Echocardiographic examination in rats and mice. Methods Mol Biol 573 (2009), 139–155.
27. 27 Richter, M.J., Sommer, N., Gall, H., Voswinckel, R., Seeger, W., Mayer, E., Wiedenroth, C.B., Rieth, A., Grimminger, F., Guth, S., Ghofrani, H.A., Pulmonary hemodynamic response to exercise in chronic thromboembolic pulmonary hypertension before and after pulmonary endarterectomy. Respiration 90 (2015), 63–73.
28. 28 Hirsch, A.M., Moser, K.M., Auger, W.R., Channick, R.N., Fedullo, P.F., Unilateral pulmonary artery thrombotic occlusion: is distal arteriopathy a consequence?. Am J Respir Crit Care Med 154 (1996), 491–496.
29. 29 Arias-Loza, P.A., Jung, P., Abeßer, M., Umbenhauer, S., Williams, T., Frantz, S., Schuh, K., Pelzer, T., Development and characterization of an inducible rat model of chronic thromboembolic pulmonary hypertension. Hypertension 67 (2016), 1000–1005.
30. 30 Nor, J.E., Christensen, J., Mooney, D.J., Polverini, P.J., Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol 154 (1999), 375–384.
31. 31 Hoeper, M.M., Mayer, E., Simonneau, G., Rubin, L.J., Chronic thromboembolic pulmonary hypertension. Circulation 113 (2006), 2011–2020.
32. 32 Dong, C., Zhou, M., Liu, D., Long, X., Guo, T., Kong, X., Diagnostic accuracy of computed tomography for chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis. PLoS One, 10, 2015, e0126985.
33. 33 Liu, M., Ma, Z., Guo, X., Zhang, H., Yang, Y., Wang, C., Computed tomographic pulmonary angiography in the assessment of severity of chronic thromboembolic pulmonary hypertension and right ventricular dysfunction. Eur J Radiol 80 (2011), e462–e469.
34. 34 Yi, E.S., Kim, H., Ahn, H., Strother, J., Morris, T., Masliah, E., Hansen, L.A., Park, K., Friedman, P.J., Distribution of obstructive intimal lesions and their cellular phenotypes in chronic pulmonary hypertension: a morphometric and immunohistochemical study. Am J Respir Crit Care Med 162 (2000), 1577–1586.
35. 35 Jamieson, S.W., Kapelanski, D.P., Pulmonary endarterectomy. Curr Probl Surg 37 (2000), 165–252.
36. 36 Azarian, R., Wartski, M., Collignon, M.A., Parent, F., Herve, P., Sors, H., Simonneau, G., Lung perfusion scans and hemodynamics in acute and chronic pulmonary embolism. J Nucl Med 38 (1997), 980–983.
37. 37 Tuder, R.M., Abman, S.H., Braun, T., Capron, F., Stevens, T., Thistlethwaite, P.A., Haworth, S.G., Development and pathology of pulmonary hypertension. J Am Coll Cardiol 54 (2009), S3–S9.
38. 38 Kasahara, Y., Tuder, R.M., Taraseviciene-Stewart, L., Le Cras, T.D., Abman, S., Hirth, P.K., Waltenberger, J., Voelkel, N.F., Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 106 (2000), 1311–1319.
39. 39 van der Laarse, A., Cobbaert, C.M., Umar, S., Stem and progenitor cell therapy for pulmonary arterial hypertension: effects on the right ventricle (2013 Grover Conference Series). Pulm Circ 5 (2015), 73–80.
40. 40 Thistlethwaite, P.A., Mo, M., Madani, M.M., Deutsch, R., Blanchard, D., Kapelanski, D.P., Jamieson, S.W., Operative classification of thromboembolic disease determines outcome after pulmonary endarterectomy. J Thorac Cardiovasc Surg 124 (2002), 1203–1211.
41. 41 Ogawa, A., Matsubara, H., Balloon pulmonary angioplasty: a treatment option for inoperable patients with chronic thromboembolic pulmonary hypertension. Front Cardiovasc Med, 2, 2015, 4.
42. 42 Shimizu, H., Tanabe, N., Terada, J., Masuda, M., Sakao, S., Kasahara, Y., Takiguchi, Y., Tatsumi, K., Kuriyama, T., Dilatation of bronchial arteries correlates with extent of central disease in patients with chronic thromboembolic pulmonary hypertension. Circ J 72 (2008), 1136–1141.
43. 43 Jandik, J., Endrys, J., Rehulova, E., Mraz, J., Sedlacek, J., De Geest, H., Bronchial arteries in experimental pulmonary infarction: angiographic and morphometric study. Cardiovasc Res 27 (1993), 1076–1083.
44. 44 McCabe, C., Deboeck, G., Harvey, I., Ross, R.M., Gopalan, D., Screaton, N., Pepke-Zaba, J., Inefficient exercise gas exchange identifies pulmonary hypertension in chronic thromboembolic obstruction following pulmonary embolism. Thromb Res 132 (2013), 659–665.
45. 45 Lang, I.M., Marsh, J.J., Olman, M.A., Moser, K.M., Loskutoff, D.J., Schleef, R.R., Expression of type 1 plasminogen activator inhibitor in chronic pulmonary thromboemboli. Circulation 89 (1994), 2715–2721.
46. 46 Wu, J., Strawn, T.L., Luo, M., Wang, L., Li, R., Ren, M., Xia, J., Zhang, Z., Ma, W., Luo, T., Lawrence, D.A., Fay, W.P., Plasminogen activator inhibitor-1 inhibits angiogenic signaling by uncoupling vascular endothelial growth factor receptor-2-alphaVbeta3 integrin cross talk. Arterioscler Thromb Vasc Biol 35 (2015), 111–120.
47. 47 Johnson, M.D., Kim, H.R., Chesler, L., Tsao-Wu, G., Bouck, N., Polverini, P.J., Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J Cell Physiol 160 (1994), 194–202.
48. 48 Alias, S., Redwan, B., Panzenbock, A., Winter, M.P., Schubert, U., Voswinckel, R., Frey, M.K., Jakowitsch, J., Alimohammadi, A., Hobohm, L., Mangold, A., Bergmeister, H., Sibilia, M., Wagner, E.F., Mayer, E., Klepetko, W., Holzenbein, T.J., Preissner, K.T., Lang, I.M., Defective angiogenesis delays thrombus resolution: a potential pathogenetic mechanism underlying chronic thromboembolic pulmonary hypertension. Arterioscler Thromb Vasc Biol 34 (2014), 810–819.
49. 49 Tolle, J.J., Waxman, A.B., Van Horn, T.L., Pappagianopoulos, P.P., Systrom, D.M., Exercise-induced pulmonary arterial hypertension. Circulation 118 (2008), 2183–2189.